It’s important that care for people with pre-existing conditions or at risk from serious diseases does not fall by the wayside.
The pharma industry claims to be patient-centric, but, asks Claus Møldrup, how can this be the case if the evolving user experience isn’t always at the forefront of the industry's mind and informing decisions?